Long-term hyperglycemia is a potential risk factor for both macro and microvascular complications. This study demonstrated the effectiveness of the Diabefly® program in participants with poorly controlled Type 2 diabetes, which is evident from the results of 49 participants showing an effective reduction in HbA1C, body weight and BMI by 3.34%, 2.41 kg and 0.82 kg/m2 from the baseline respectively. Similarly, a crucial mean reduction in waist circumference, carbohydrate and total calorie intake was observed among participants with respective complete data from the baseline.